Vertex Pharmaceuticals (VRTX) Shares Outstanding (2009 - 2026)

Vertex Pharmaceuticals' Shares Outstanding history runs 18 years deep, the most recent figure standing at $254.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding fell 1.1% year-over-year to $254.2 million; the TTM figure through Mar 2026 stood at $254.2 million (down 1.1% YoY), while the FY2025 annual figure was $254.0 million, down 1.13% from the prior year.
• Shares Outstanding was $254.2 million for Q1 2026 at Vertex Pharmaceuticals, roughly flat from $254.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $258.3 million in Q1 2024 to a low of $254.0 million in Q3 2025.
• Historically, Shares Outstanding has averaged $256.6 million across 5 years, with a median of $257.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding increased 0.98% in 2022, then declined 1.45% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $257.0 million in 2022, then climbed by 0.27% to $257.7 million in 2023, then decreased by 0.31% to $256.9 million in 2024, then slipped by 1.13% to $254.0 million in 2025, then climbed by 0.07% to $254.2 million in 2026.
• The last three Shares Outstanding figures came in at $254.2 million (Q1 2026), $254.0 million (Q4 2025), and $254.0 million (Q3 2025), per Business Quant data.